About this document
β-D-Glucan by cheryldaigdigan23 is a document available to read on EtoBox.
The study investigates the antiviral efficacy of β-D-glucan (BDG) against dengue virus (DENV) in human liver cells, revealing that BDG effectively inhibits DENV replication at a concentration of 400 μg/mL with minimal cytotoxicity. Various assays demonstrated that BDG binds to DENV-2 and significantly reduces plaque formation, indicating its potential as an antiviral agent. The findings suggest that BDG could be a promising therapeutic option for managing DENV infections.
- Author
- cheryldaigdigan23
- Language
- EN